Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 10/20 | 0.85 |
| ▸ | SRC | P12931 | 5/20 | 0.85 |
| ▸ | LCK | P06239 | 4/20 | 0.85 |
| ▸ | PKMYT1 | Q99640 | 3/20 | 0.85 |
| ▸ | EPHB6 | O15197 | 2/20 | 0.85 |
| ▸ | EGFR | P00533 | 2/20 | 0.85 |
| ▸ | FYN | P06241 | 2/20 | 0.85 |
| ▸ | CSF1R | P07333 | 2/20 | 0.85 |
| ▸ | YES1 | P07947 | 2/20 | 0.85 |
| ▸ | LYN | P07948 | 2/20 | 0.85 |
| ▸ | RET | P07949 | 2/20 | 0.85 |
| ▸ | HCK | P08631 | 2/20 | 0.85 |
| ▸ | KIT | P10721 | 2/20 | 0.85 |
| ▸ | BCR | P11274 | 2/20 | 0.85 |
| ▸ | BRAF | P15056 | 2/20 | 0.85 |
| ▸ | EPHA1 | P21709 | 2/20 | 0.85 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.85 |
| ▸ | EPHA3 | P29320 | 2/20 | 0.85 |
| ▸ | EPHA8 | P29322 | 2/20 | 0.85 |
| ▸ | EPHB2 | P29323 | 2/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dasatinib Anhydrous SCHEMBL28361868 | 0.92 | ABL1 (0.97) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL28350326 | 0.92 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL29381185 | 0.92 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL8226 | 0.92 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL29482416 | 0.91 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL29377489 | 0.91 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL28432270 | 0.91 | ABL1 (0.98) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL1705152 | 0.91 | ABL1 (0.98) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL20857008 | 0.91 | ABL1 (0.98) | ABL1SRCLCKPKMYT1EPHB6 | |
| Dasatinib Anhydrous SCHEMBL16618598 | 0.91 | ABL1 (1.00) | ABL1SRCLCKPKMYT1EPHB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951906-A2 | MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS | Bristol-Myers Squibb Pharma Company (US) | 2008-08-06 | — | — | EP | claimed |
| WO-2007059430-A2 | MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-05-24 | — | — | WO | claimed |
| WO-2007056177-A9 | T315A AND F317I MUTATIONS OF BCR-ABL KINASE DOMAIN | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2008-06-26 | — | — | WO | disclosed |